DOJ's partial rescheduling of cannabis leaves federal legalization unresolved
The DOJ moved certain marijuana products—from FDA-approved items to state-licensed medical cannabis—from Schedule I to Schedule III, a narrow step that allows medical prescriptions but does not legalize cannabis federally or for recreation. Enforcement remains discretionary, and ongoing lawsuits challenge the order, while states continue operating under a patchwork system with broad public support for legalization but no federal change on the horizon.